Understanding current frontline treatment: COG and SIOPEN
In this session from Solving Kids’ Cancer UK's Neuroblastoma Parent Symposium 2026, experts provide an in-depth overview of current frontline treatment approaches for high-risk neuroblastoma. The presentation explores how treatment is delivered through the Children’s Oncology Group (COG) in the United States and SIOPEN (International Society of Paediatric Oncology Europe Neuroblastoma) in Europe, highlighting current standards of care and key differences between the two approaches.
-
Need to speak with someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to see how we can support you.
-
Treatment for neuroblastomaRead more about the different types of treatment for neuroblastoma.
-
High-risk neuroblastomaFind all the relevant information for high-risk neuroblastoma in one place.
Related videos
-
Video (2026)Finding trusted information
Explores how families can find trusted, evidence-based information about neuroblastoma, shares a parent's experience of reliable sources, and highlights the role of the National Neuroblastoma Advisory Panel.
-
Video (2025)What is neuroblastoma?
Overview of neuroblastoma, including how the disease develops, its characteristics, diagnosis, risk classification, and standard treatment approaches.
-
VideoCoping with diagnosis
A supportive introduction for families after a neuroblastoma diagnosis, covering key terms, treatment, and managing side effects.